XFOR Annual Interest Expense
$5.78 M
+$1.78 M+44.68%
31 December 2023
Summary:
As of January 23, 2025, XFOR annual interest expense is $5.78 million, with the most recent change of +$1.78 million (+44.68%) on December 31, 2023. During the last 3 years, it has risen by +$3.09 million (+114.92%). XFOR annual interest expense is now at all-time high.XFOR Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR Quarterly Interest Expense
$2.41 M
+$238.00 K+10.94%
30 September 2024
Summary:
As of January 23, 2025, XFOR quarterly interest expense is $2.41 million, with the most recent change of +$238.00 thousand (+10.94%) on September 30, 2024. Over the past year, it has increased by +$238.00 thousand (+10.94%). XFOR quarterly interest expense is now at all-time high.XFOR Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR TTM Interest Expense
$8.35 M
+$780.00 K+10.30%
30 September 2024
Summary:
As of January 23, 2025, XFOR TTM interest expense is $8.35 million, with the most recent change of +$780.00 thousand (+10.30%) on September 30, 2024. Over the past year, it has increased by +$780.00 thousand (+10.30%). XFOR TTM interest expense is now at all-time high.XFOR TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.7% | +10.9% | +10.3% |
| 3 y3 years | +114.9% | +10.9% | +10.3% |
| 5 y5 years | +702.4% | +250.9% | +288.9% |
XFOR Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.6% | at high | +164.4% | at high | +129.3% |
| 5 y | 5-year | at high | +169.1% | at high | +340.5% | at high | +288.9% |
| alltime | all time | at high | +1123.9% | at high | +3813.8% | at high | +1059.7% |
X4 Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.41 M(+10.9%) | $8.35 M(+10.3%) |
| June 2024 | - | $2.18 M(+16.1%) | $7.57 M(+15.7%) |
| Mar 2024 | - | $1.87 M(-0.6%) | $6.54 M(+13.2%) |
| Dec 2023 | $5.78 M(+44.7%) | $1.89 M(+15.4%) | $5.78 M(+14.7%) |
| Sept 2023 | - | $1.63 M(+42.3%) | $5.04 M(+13.9%) |
| June 2023 | - | $1.15 M(+3.5%) | $4.42 M(+5.5%) |
| Mar 2023 | - | $1.11 M(-3.1%) | $4.19 M(+4.9%) |
| Dec 2022 | $3.99 M(+9.6%) | $1.14 M(+12.4%) | $3.99 M(+5.8%) |
| Sept 2022 | - | $1.02 M(+10.9%) | $3.77 M(+2.7%) |
| June 2022 | - | $918.00 K(+0.5%) | $3.68 M(+0.4%) |
| Mar 2022 | - | $913.00 K(-1.3%) | $3.66 M(+0.6%) |
| Dec 2021 | $3.64 M(+35.5%) | $925.00 K(+0.5%) | $3.64 M(+6.0%) |
| Sept 2021 | - | $920.00 K(+1.7%) | $3.44 M(+6.9%) |
| June 2021 | - | $905.00 K(+1.6%) | $3.21 M(+7.3%) |
| Mar 2021 | - | $891.00 K(+23.8%) | $3.00 M(+11.4%) |
| Dec 2020 | $2.69 M | $720.00 K(+3.3%) | $2.69 M(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $697.00 K(+1.5%) | $2.52 M(+0.4%) |
| June 2020 | - | $687.00 K(+17.6%) | $2.51 M(+7.5%) |
| Mar 2020 | - | $584.00 K(+6.6%) | $2.33 M(+8.6%) |
| Dec 2019 | $2.15 M(+198.2%) | $548.00 K(-20.3%) | $2.15 M(+40.0%) |
| Sept 2019 | - | $688.00 K(+34.4%) | $1.53 M(+38.8%) |
| June 2019 | - | $512.00 K(+28.3%) | $1.10 M(+29.7%) |
| Mar 2019 | - | $399.00 K(-713.8%) | $852.00 K(+18.3%) |
| Dec 2018 | $720.00 K(-65.4%) | -$65.00 K(-125.1%) | $720.00 K(-31.9%) |
| Sept 2018 | - | $259.00 K(0.0%) | $1.06 M(-7.4%) |
| June 2018 | - | $259.00 K(-3.0%) | $1.14 M(-13.9%) |
| Mar 2018 | - | $267.00 K(-2.2%) | $1.33 M(-36.2%) |
| Dec 2017 | $2.08 M(-17.3%) | $273.00 K(-20.4%) | $2.08 M(-20.0%) |
| Sept 2017 | - | $343.00 K(-22.7%) | $2.60 M(+15.2%) |
| June 2017 | - | $444.00 K(-56.4%) | $2.25 M(+24.5%) |
| Mar 2017 | - | $1.02 M(+28.7%) | $1.81 M(+128.7%) |
| Dec 2016 | $2.52 M(+432.8%) | $792.00 K | $792.00 K |
| Dec 2015 | $472.00 K | - | - |
FAQ
- What is X4 Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual interest expense year-on-year change?
- What is X4 Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly interest expense year-on-year change?
- What is X4 Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM interest expense year-on-year change?
What is X4 Pharmaceuticals annual interest expense?
The current annual interest expense of XFOR is $5.78 M
What is the all time high annual interest expense for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual interest expense is $5.78 M
What is X4 Pharmaceuticals annual interest expense year-on-year change?
Over the past year, XFOR annual interest expense has changed by +$1.78 M (+44.68%)
What is X4 Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of XFOR is $2.41 M
What is the all time high quarterly interest expense for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly interest expense is $2.41 M
What is X4 Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, XFOR quarterly interest expense has changed by +$238.00 K (+10.94%)
What is X4 Pharmaceuticals TTM interest expense?
The current TTM interest expense of XFOR is $8.35 M
What is the all time high TTM interest expense for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM interest expense is $8.35 M
What is X4 Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, XFOR TTM interest expense has changed by +$780.00 K (+10.30%)